*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Ciba-Geigy/NNP Ltd./NNP ]
and/CC 
[ Chiron/NNP Corp./NNP ]
began/VBD 
[ their/PRP$ ]
previously/RB announced/VBN 
[ $/$ 591/CD million/CD ]
,/, or/CC 
[ $/$ 25.23-a-share/JJ ]
,/, offer/NN for/IN 
[ the/DT shares/NNS ]
of/IN 
[ Connaught/NNP BioSciences/NNP Inc./NNP ]
that/IN 
[ they/PRP ]
do/VBP n't/RB already/RB own/VB ./. 

======================================

As/IN previously/RB reported/VBN ,/, 
[ the/DT offer/NN ]
for/IN 
[ the/DT Toronto-based/JJ vaccine/NN ]
and/CC 
[ pharmaceutical/JJ company/NN ]
is/VBZ contingent/JJ upon/IN 
[ the/DT tender/NN ]
of/IN at/IN 
[ least/JJS 11/CD million/CD Connaught/NNP shares/NNS ]
and/CC 
[ the/DT rejection/NN ]
by/IN 
[ Connaught/NNP shareholders/NNS ]
of/IN 
[ a/DT rival/JJ stock-swap/JJ offer/NN ]
from/IN 
[ Institut/NNP Merieux/NNP S.A./NNP ]
of/IN 
[ France/NNP ]
,/, 
[ 50.3/CD %/NN ]
controlled/VBN by/IN 
[ Rhone-Poulenc/NNP S.A./NNP ]
,/, 
[ France/NNP ]
./. 

======================================

[ Ciba-Geigy/NNP ]
,/, 
[ the/DT Basel/NNP ]
,/, 
[ Switzerland-based/JJ pharmaceutical/JJ concern/NN ]
,/, and/CC 
[ Chiron/NNP ]
,/, 
[ an/DT Emeryville/NNP ]
,/, 
[ Calif./NNP ]
,/, 
[ biotechnology/NN concern/NN ]
,/, already/RB 
[ own/VBP 8/CD %/NN ]
,/, or/CC 
[ 2,045,640/CD shares/NNS ]
,/, of/IN 
[ Connaught/NNP 's/POS 25.5/CD million/CD shares/NNS ]
on/IN 
[ a/DT ]
fully/RB diluted/VBN 
[ basis/NN ]
./. 

If/IN 
[ the/DT minimum/NN 11/CD million/CD shares/NNS ]
are/VBP tendered/VBN ,/, 
[ Ciba-Geigy/NNP ]
and/CC 
[ Chiron/NNP ]
,/, through/IN 
[ a/DT unit/NN ]
created/VBN for/IN 
[ the/DT acquisition/NN ]
,/, would/MD gain/VB 
[ control/NN ]
of/IN 
[ 51/CD %/NN ]
of/IN 
[ the/DT Canadian/JJ firm/NN ]
./. 

======================================

[ Ciba-Geigy/NNP ]
and/CC 
[ Chiron/NNP ]
said/VBD 
[ the/DT offer/NN ]
will/MD remain/VB 
[ open/JJ ]
through/IN 
[ midnight/NN Toronto/NNP time/NN Oct./NNP 17/CD ]
,/, unless/IN 
[ it/PRP ]
's/VBZ withdrawn/VBN or/CC extended/VBN ./. 
